Skip to content
healthcare.dev

Tamiflu

NDC 0004-0822, Oseltamivir Phosphate, powder, for suspension, from Genentech, Inc..

Product NDC
0004-0822
Status
Listed
Labeler
Genentech, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0004-0822 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
0004-0822-05000040822051 BOTTLE, GLASS in 1 CARTON (0004-0822-05) / 60 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ee3c9555-60f2-4f82-a760-11983c86e97b
  • NADAC price for package 00004082205

    GET /v1/drugs/nadac/00004082205

Use it

Look up 0004-0822 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0004-0822 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0004-0822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.